By Ben Hirschler LONDON (Reuters) - Consumers and the pharmaceuticals industry alike are anxious about medicine supplies, if there is no deal on Britain's departure from the European Union. While the EU and Britain have agreed a draft text of a Brexit withdrawal agreement, it remains unclear if Prime Minister Theresa May can get it approved by parliament. The highly regulated drugs sector is vulnerable to a no-deal Brexit due to uncertainty over how supply chains and regulatory oversight will function, and the UK government has told companies to build an additional six weeks of drug stockpiles.
from Latest News Business on Firstpost https://ift.tt/2K6wO7i
Wednesday, 14 November 2018
Patients and industry fret over drug supplies, if no Brexit deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment